Sunlenca 300 mg Film-Coated Tablets: Uses and Side Effects
Quick summary: Sunlenca 300 mg film-coated tablets contain lenacapavir and are used in adults with multidrug-resistant HIV-1. They are part of a treatment plan that may include other antiretroviral medicines and a scheduled injection....
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Sunlenca 300 mg film-coated tablets contain lenacapavir and are used in adults with multidrug-resistant HIV-1. They are part of a treatment plan that may include other antiretroviral medicines and a scheduled injection.
This page explains the main uses, how the treatment is given, possible side effects, and safety points to review with a healthcare professional or the official leaflet.
Medical disclaimer: This article is for general information only and does not replace advice from a doctor, pharmacist, or the official patient information leaflet. Do not use it to diagnose a condition or to change any prescribed treatment.
What are Sunlenca 300 mg film-coated tablets?
Sunlenca 300 mg film-coated tablets are a medicine used in adults with multidrug-resistant HIV-1. The active ingredient is lenacapavir.
They are intended for people who have limited treatment options because previous antiviral therapies have not worked well enough.
What is Sunlenca used for?
Sunlenca is primarily prescribed for the treatment of multidrug-resistant HIV-1 infection in adults.
It is used as part of a broader antiretroviral treatment plan. In practice, this means a clinician may combine it with other HIV medicines based on the person’s treatment history and current needs.
How does Sunlenca work?
Lenacapavir works as a capsid inhibitor. In simple terms, it targets a part of the HIV virus involved in replication and maturation.
This helps reduce the virus’s ability to spread in the body. The medicine is designed for use in resistant HIV-1 infection, where treatment choices may be limited.
How is Sunlenca taken?
Sunlenca should be taken exactly as prescribed by the healthcare provider.
The current content describes an initial oral dosing phase followed by a subcutaneous injection on Day 15. It also notes that the tablets can be taken with or without food.
Because HIV treatment schedules can be complex, patients should confirm the exact dosing plan, timing, and follow-up appointments with their clinician or pharmacist.
| Topic | What the current content says |
|---|---|
| Use | Treatment for multidrug-resistant HIV-1 in adults |
| Active ingredient | Lenacapavir |
| Administration | Oral tablets as part of an initial phase, followed by an injection |
| Food | Can be taken with or without food |
What are the possible side effects?
Like all medicines, Sunlenca can cause side effects. The current content mentions nausea and mild gastrointestinal symptoms.
It also mentions immune reconstitution syndrome, which can happen when the immune system begins to recover and may lead to inflammation or symptoms related to previously hidden infections.
Any new, persistent, or worsening symptoms should be discussed with a healthcare professional.
What precautions should be considered?
Before using Sunlenca, the current content advises patients to tell their healthcare provider about:
- Any allergies
- Kidney or liver problems
- All other medicines being taken
- Pregnancy or plans to become pregnant
The content also notes that strong CYP3A inducers may reduce the medicine’s effectiveness, so medication review is important.
What should patients verify with a doctor or pharmacist?
Because treatment plans can vary, it is sensible to confirm the following before and during use:
- The exact dosing schedule
- How the tablets fit into the full HIV treatment plan
- Whether any current medicines may interact with lenacapavir
- What symptoms should prompt urgent medical advice
- What the official leaflet says about missed doses and follow-up care
Frequently asked questions
▸ What is Sunlenca used for?
Sunlenca is used for treating multidrug-resistant HIV-1 infection in adults, usually as part of a broader antiretroviral treatment plan.
▸ What is the active ingredient in Sunlenca?
The active ingredient is lenacapavir.
▸ Can Sunlenca be taken with food?
The current content says it can be taken with or without food.
▸ What side effects are mentioned in the article?
Nausea, mild gastrointestinal symptoms, and immune reconstitution syndrome are mentioned in the source content.
▸ Why is medication review important with Sunlenca?
The source content notes that strong CYP3A inducers may reduce effectiveness, so a clinician or pharmacist should review all medicines for possible interactions.
Safety reminder
HIV treatment should be managed by a qualified healthcare professional. If you have questions about your prescription, side effects, pregnancy, other medicines, or the timing of injections and tablets, check the official leaflet or speak with your doctor or pharmacist.
Do not use this page as a substitute for personalised medical advice.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.